These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 10804044
1. Ebastine: an update of its use in allergic disorders. Hurst M, Spencer CM. Drugs; 2000 Apr; 59(4):981-1006. PubMed ID: 10804044 [Abstract] [Full Text] [Related]
2. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Wiseman LR, Faulds D. Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167 [Abstract] [Full Text] [Related]
3. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders. Van Cauwenberge P, De Belder T, Sys L. Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995 [Abstract] [Full Text] [Related]
4. Ebastine in allergic rhinitis and chronic idiopathic urticaria. Sastre J. Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340 [Abstract] [Full Text] [Related]
5. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group. Ratner PH, Lim JC, Georges GC. J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142 [Abstract] [Full Text] [Related]
6. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis. Ratner P, Falqués M, Chuecos F, Esbrí R, Gispert J, Peris F, Luria X, Rosales MJ. Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195 [Abstract] [Full Text] [Related]
7. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Simpson K, Jarvis B. Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552 [Abstract] [Full Text] [Related]
10. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Kalis B. Drugs; 1996 Feb; 52 Suppl 1():30-4. PubMed ID: 8828024 [Abstract] [Full Text] [Related]
11. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults. Gehanno P, Bremard-Oury C, Zeisser P. Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684 [Abstract] [Full Text] [Related]
12. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study. Guadaño EM, Serra-Batlles J, Meseguer J, Castillo JA, De Molina M, Valero A, Picado C, Rupatadine Study Group. Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765 [Abstract] [Full Text] [Related]
15. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study. Ratner P, Hampel F, Van Bavel J, Howland W. Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611 [Abstract] [Full Text] [Related]
16. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects. Chaikin P, Gillen MS, Malik M, Pentikis H, Rhodes GR, Roberts DJ. Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381 [Abstract] [Full Text] [Related]
17. Cetirizine: a review of its use in allergic disorders. Curran MP, Scott LJ, Perry CM. Drugs; 2004 Mar; 64(5):523-61. PubMed ID: 14977391 [Abstract] [Full Text] [Related]
19. A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis. Frank H, Gillen M, Rohatagi SS, Lim J, George G, Ebastine Study Group. J Clin Pharmacol; 2002 Oct; 42(10):1097-104. PubMed ID: 12362923 [Abstract] [Full Text] [Related]
20. Rupatadine: a review of its use in the management of allergic disorders. Keam SJ, Plosker GL. Drugs; 2007 Oct; 67(3):457-74. PubMed ID: 17335300 [Abstract] [Full Text] [Related] Page: [Next] [New Search]